The pharmaceutical giant announced its decision to cancel its planned investment just two days after Chancellor Rachel Reeves set out Labour's plan to go "further and faster" to boost economic growth.

In 2023, it was announced the Covid-19 vaccine AstraZeneca would no longer be available in Australia from March 21st. It came after there was link found between the vaccine and a rare but serious ...

Global pharmaceutical giant AstraZeneca has completed a state-of-the-art solar panel installation at its Macquarie Park ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision ...

AstraZeneca's Calquence is also under review by regulatory authorities in Australia, Canada, Switzerland, the EU, Japan, and other countries based on the ECHO trial results. The drug is part of ...

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m ...

These approvals were based on the outcomes from the CAPItello-291 study, while the drug is also approved in Australia for similar indications. AstraZeneca developed the drug in partnership with ...